HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanical ventricular assist device as a bridge to recovery post-ABO-incompatible heart transplantation for failed Fontan circulation.

Abstract
A girl received an ABO-incompatible heart transplantation (ABOiHTx) at the age of 3.5 years for failed univentricular palliation with protein-losing enteropathy (PLE). She was born with a hypoplastic left heart syndrome and underwent multistage palliation to a Fontan circulation at 2½ years of age. After the Fontan surgery, she developed PLE, necessitating a Fontan revision, followed by a Fontan takedown and eventually HTx, which was performed with a blood group B heart into an O recipient. Right ventricular (RV) failure secondary to increased pulmonary vascular resistance (PVR) evolved immediately after HTx. A temporary right ventricular assist device (RVAD) was implanted and later switched to a pneumatic pulsatile RVAD. With the adaption of PVR on the RVAD, the PLE resolved and the RVAD was explanted. In the following 12 months, she developed multiple relapses of PLE which eventually resolved after exchange of the calcineurin inhibitor.
AuthorsStefanie Seitz, Holger Buchholz, Ivan Rebeyka, David Ross, Lori West, Simon Urschel
JournalTransplant international : official journal of the European Society for Organ Transplantation (Transpl Int) Vol. 27 Issue 7 Pg. e54-7 (Jul 2014) ISSN: 1432-2277 [Electronic] Switzerland
PMID24628869 (Publication Type: Case Reports, Journal Article)
Copyright© 2014 Steunstichting ESOT.
Chemical References
  • ABO Blood-Group System
Topics
  • ABO Blood-Group System
  • Blood Group Incompatibility (therapy)
  • Child, Preschool
  • Female
  • Fontan Procedure (adverse effects)
  • Heart Failure (physiopathology)
  • Heart Transplantation
  • Heart-Assist Devices
  • Humans
  • Protein-Losing Enteropathies (etiology, therapy)
  • Treatment Outcome
  • Ventricular Dysfunction, Right (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: